Authors:
Lammering, G
Hewit, TH
Hawkins, WT
Contessa, JN
Reardon, DB
Lin, PS
Valerie, K
Dent, P
Mikkelsen, RB
Schmidt-Ullrich, RK
Citation: G. Lammering et al., Epidermal growth factor receptor as a genetic therapy target for carcinomacell radiosensitization, J NAT CANC, 93(12), 2001, pp. 921-929
Authors:
Dent, P
Logsdon, C
Nicke, B
Valerie, K
Farnsworth, J
Schmidt-Ullrich, R
Reardon, DB
Citation: P. Dent et al., Recombinant adenoviral expression of dominant-negative Ras N17 blocking radiation-induced activation of mitogen-activated protein kinase pathway, METH ENZYM, 333, 2001, pp. 28-37
Authors:
Contessa, JN
Reardon, DB
Todd, D
Dent, P
Mikkelsen, RB
Valerie, K
Bowers, GD
Schmidt-Ullrich, RK
Citation: Jn. Contessa et al., The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells, CLIN CANC R, 5(2), 1999, pp. 405-411
Authors:
Dent, P
Reardon, DB
Park, JS
Bowers, G
Logsdon, C
Valerie, K
Schmidt-Ullrich, R
Citation: P. Dent et al., Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death, MOL BIOL CE, 10(8), 1999, pp. 2493-2506
Authors:
Reardon, DB
Contessa, JN
Mikkelsen, RB
Valerie, K
Amir, C
Dent, P
Schmidt-Ullrich, RK
Citation: Db. Reardon et al., Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activationand enhance radiation toxicity of human mammary carcinoma cells, ONCOGENE, 18(33), 1999, pp. 4756-4766